Sign In | Join Free | My himfr.com |
|
Ask Lasest Price | |
Brand Name : | ZOSBIO |
Model Number : | 2019-nCoV Ag Saliva/Sputum |
Certification : | CE BfArm |
Price : | To be negotiated |
Supply Ability : | 10000 Kit/Kit per Day |
Delivery Time : | To be negotiated |
The kit will be used for qualitative testing of new corona virus
antigens in 2019. Collection of human saliva/sputum samples.
The new corona virus is a new corona virus that may cause viral
pneumonia. Clinical symptoms are fever, tiredness, dry cough, a
small number of patients with nasal congestion, runny nose, sore
throat, diarrhea and other symptoms. Severe patients usually
develop dyspnea and/or hypoxemia one week later, and severe
patients develop acute dyspnea syndrome, septic shock, metabolic
similarity, and coagulation dysfunction.
Using cross-flow Imunosai, the legitimacy of new coronavirus
antigens in suspected saliva/sputum specimens was detected.
Antigens are usually detected in saliva/sputum samples of infection
during the acute period. A positive result indicates the presence
of viral antigens, but clinical correlations between the history
and other diagnostic information are also necessary to determine
the status of infection. A positive result does not rule out
bacterial or other virus-related infections. The pathogen detected
may not be the correct cause of infection. Negative disease outcome
should not exclude COVID-19 infection in 2019, but should be used
as a basis for treatment or patient management decisions, including
infection management decisions. A negative result needs to be
confirmed based on the patient's recent exposure, past medical
history, and nucleic acid analysis of new coronavirus-related
clinical symptoms and symptoms.
The kit consists of test card, sample buffer storage and swab.
Test card: aluminum foil bag, desiccant, test strip, plastic card
composition. The paper consists of suction paper, nitrocellulose
film, sample pad, rubber pad and tape. Contains a 2019
nitrocellulocellulose membrane T-line (test line) encased with NCOV
Ab, a C-line (QC line) encased with goat anti-globular antibody,
and a binding pad for the 2019-NCOVAB label.
Sample buffer: phosphate, naphthalene azo, etc.
The temperature is temporarily maintained at 2-30 ℃ for 18 months.
Wheler package is valid for 1 hour after opening.
Production Lot Number: Refer to the label for details.
Expiry date: Refer to the label.
(1) Saliva sampling: do not eat or drink chewing gum or cigarette
products within 30 minutes after saliva sampling. Place the tip of
the tongue on the mouth lid to collect the roots of saliva. Place a
disposable disinfecting swab under the saliva sample. Use the tip
of your tongue for at least 10 seconds, soaking it completely in
saliva and rotating it more than 5 times. (See Table 1)
Note: Saliva samples were collected incorrectly.
Figure 1 Methodsfor saliva sample collection
Figure 2 Methods for sputum sample collection
(2) Sputum collection: wash the sputum with water, put the sputum
into the test bag, and wipe the sputum with a disposable sterile
cotton stick. (Refer to Figure 2)
(3) Sample processing: Use the sample buffer storage contained in
the supporting components to process the collected samples (samples
that are not immediately discarded must be stored in a dry and
germicidal sealed container). 2-8 degrees Celsius to 24 hours,
above 70 degrees Celsius (however, please avoid repeated freezing
and thawing).
Please read the instructions carefully before the test. All
reagents are returned to room temperature and tested at room
temperature.
Processing example (see Figure 3).
(1) Insert the sample exchanger into the sample buffer memory,
rotate it around the inner wall for about 10 times, and dissolve
the sample in solution as much as possible.
(2) Press the casing head along the inner wall to make the liquid
flow into the pipe, remove the casing and discard it.
(3) Cover with small water drops.
Figure 3 Sample processing
Figure 4 Test procedure
2. Test process (see Figure 4).
(1) Remove the test card.
(2) Add 2 drops (~ 80L) of treated sample extract to the sample
well of the test card and start timing.
(3) Read the card for 15 minutes at room temperature, and the
result is invalid after 20 minutes.
Figure 5 Interpretation of test results
1. This product is a qualitative test intended only to support
INVitro diagnostics.
2. This product is suitable for saliva and sputum samples. Other
types of samples may be incorrect or invalid.
3. In the absence of sputum samples, patients should be examined
with a nasopharyngeal swan.
4. Please add a suitable amount of samples for testing. Or, if
there are too many samples, the results may be incorrect.
5. The test results of the reagent are for clinical reference only,
and should not be used as the sole basis for clinical diagnosis and
treatment. The combined evaluation of all clinical and examination
results leads to a definitive diagnosis of the disease.
1. Detection limits: Inactive SARS-CCOV-2 virus cultures were used
in this study. The minimum detection limit is 610TCID50 / mL.
2. The company's standard materials shall be used in the
examination, and the test results shall meet the requirements of
the company's standard materials.
2.1 Qualification rate of active management: p1-P5.
2.2 Negative control pass rate: N1-N10 Negative control test is
negative.
2.3 Test limit: please refer to L1-L3. L1 is negative, L2 and L3
are positive.
2.4 Reproducibility: J1 and J2 are positive 10 times.
3 cross-reactivity: The following microorganisms and viruses were
injected into the sample at specific concentrations to evaluate
potential interference with the 2019 new corona virus antigen
detection program.
4. Interference: the 2019nCoV Ag detection step evaluates potential
interference and adds the following agents at specified
concentrations. The results show that various drugs do not
interfere with the result of reagent detection.
5. Hook effect: There is no hook effect within the high
concentration range of 1.0106 TCID50/mL.
6. Clinical studies: The RT-PLR sputum reagent was used as a
control reagent to detect saliva and sputum samples separately. For
each sample size (RT-PLR test), 120 positive and negative samples
were selected for a second test using the XIUS reagent. The
findings are summarized below.
1. This product is used for INVitro diagnosis.
This product is disposable and can't be reused.
3. Please strictly follow the instructions of reagents. Please read
the instructions carefully before the experiment.
4. Do not perform the test under severe environmental conditions
(including 84 disinfectants, dust, sodium hypochlorite, acid and
alkali, acetaldehyde and other corrosive gases with high
concentration). Disinfection of the laboratory must be carried out
after the experiment.
![]() |